Investival ShowcaseMonday, 17 November 2025 - GMT (Greenwich Mean Time, GMTZ)

The session will discuss key considerations and potential issues to think about when preparing your biotech company for M&A, including:

· How to set your biotech company up for a successful transaction

· Types of purchasers and deal structures

· Due diligence preparation

· W&I insurance

· An overview of the key transaction documents

· How to maximise value on an exit, including current trends in biotech M&A and alternative deal structures

Unlock the secrets of successful pharma-startup partnerships in this masterclass designed specifically for life science entrepreneurs. Learn from industry experts who understand the complex dynamics of strategic alliances that can accelerate your innovation from lab to market.

• Demonstrate how early-stage pharma collaborations can significantly enhance your startup's validation and success rates

• Learn about the unique value a pharma-backed incubator facility can bring to your startup

• Equip you with tools to leverage partnerships for accessing critical resources, expertise, and market channels

• Include interactive sessions with industry experts who have successfully navigated partnerships from both sides of the table

This masterclass delves into the shifting landscape of licensing and partnering within the biopharma sector, offering actionable strategies for deal structuring, negotiation, and commercialization amid evolving market forces, regulatory frameworks, and technological innovation. Key focus areas include:

• Strategic Deal Structuring
  Aligning licensing and partnering models with long-term commercial objectives
• Capital Constraints and Deal Evolution
  Adapting deal terms to navigate tighter funding environments
• Regulatory and Market Access Dynamics
  Responding to policy changes and their implications for partnership models
• Technology Disruption: AI and Beyond
  Exploring how emerging technologies are reshaping IP strategy and deal-making
• Innovative Commercialization Pathways
  Trends in co-commercialization, regional licensing, and revenue-sharing frameworks
• Negotiation Mastery
  Practical techniques for driving value and securing strategic outcomes

• Status of the US IPO market in comparison to the EU/UK – current state of the US IPO market and outlook for the coming year
• Pre-IPO readiness check – what do you need in place to ensure you are in the best position for your IPO
• Understanding investor expectation and your equity story and why it is key to success – fireside chat
• What to expect from the IPO process – a summary view of the key elements of the active phase of the transaction
• Key lessons learned from previous transactions – highlighting the known unknowns
• Post-IPO and beyond – understanding your requirements as a listed company

This comprehensive masterclass equips life science entrepreneurs with essential strategies to build, protect, and leverage intellectual property assets that drive company valuation and create sustainable competitive advantages in the rapidly evolving healthcare innovation landscape.

This masterclass will:

• Provide practical frameworks for developing a strategic IP portfolio that aligns with your business objectives and therapeutic focus

• Deliver expert guidance on patent strategies specific to various life science modalities including biologics, gene therapies, and digital health

• Equip you with effective approaches to navigate freedom-to-operate challenges and competitive IP landscapes

• Demonstrate how to leverage IP assets in fundraising, partnerships, and exit strategies to maximize company valuation

• Guide you through critical decisions on global filing strategies and cost-effective IP management for resource-constrained startups

• Include interactive sessions with experienced IP attorneys and life science executives who have successfully built valuable IP portfolios